Sort
59,101 grants matching “hypertension”
Hypertension augmented COVID-19 through renin-induced internalization of platelet-ACE2 / SARS-Cov-2 complexes
$572,341Thomas M McIntyre · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL
Quantification of Liver Fibrosis with MRI and Deep Learning
$572,327Lili He · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · EB
Environmental health disparities research in NOCEMHD
$572,320Jose A Luchsinger · Columbia University Health Sciences · P60 · FY2011 · MD
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
$572,309Masako Morishita · Michigan State University · R01 · FY2020 · NR
AT1 Receptor Control in Chronic Hypertension Attenuation
$572,278Mohan K. Raizada · University Of Florida · R01 · FY2006 · HL
A Prospective Cohort Study of Migraines, Platelet Activation, and Preeclampsia
$572,256Michelle A Williams · Swedish Medical Center, First Hill · R01 · FY2010 · HD
Roles of SLC26A6 in Renal NaCI Transport and Prevention of Oxalate Urolithiasis
$572,226Peter S Aronson · Yale University · R37 · FY2010 · DK
Sleep and cardio-metabolic risk factors: a prospective study of adolescents
$572,179Edward O. Bixler · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · HL
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
$572,149Mark J Siedner · Kwazulu-Natal Research Institute Tb-Hiv · R01 · FY2024 · HL
Genomics of Intracerebral Hemorrhage and its Causes
$572,075Frank R Sharp · University Of California At Davis · R01 · FY2023 · NS
Blockade of S1P pathway for renal fibrosis therapy
$572,063Webster L Santos · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · DK
Vascular disease pathogenesis: the interface of smooth muscle and immune cells
$572,053Daniel Greif · Yale University · R01 · FY2018 · HL
Vascular disease pathogenesis: the interface of smooth muscle and immune cells
$572,053Daniel Greif · Yale University · R01 · FY2019 · HL
The African-American Health Improvement Partnership
$572,046Sherman A James · Duke University · R24 · FY2006 · MD
An Integrative Genomic Approach to APOL1-Associated Nephropathy.
$572,026Barry Ira Freedman · Wake Forest University Health Sciences · R01 · FY2013 · DK
Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults
$571,966Douglas R Seals · University Of Colorado · R01 · FY2020 · AG
Training in Signature Transdisciplinary Cardiovascular Sciences
$571,962Mary G Sorci-Thomas · Medical College Of Wisconsin · T32 · FY2025 · HL
CAREER: Towards Deep Interpretable Predictions for Multi-Scope Temporal Events
$571,930Yue M Ning · Stevens Institute Of Technology · · FY2021 · CSE
Rhythm and Timing Exercises for Cerebral Vascular Disease in American Indians
$571,923Steven P. Verney · University Of New Mexico · R01 · FY2015 · AG
Immune Mechanisms of Salt-Sensitive hypertension
$571,886Annet Kirabo · Vanderbilt University Medical Center · R01 · FY2025 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2017 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2019 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2016 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2018 · HL
Psychological, Physiological, and Behavioral Effects of Weight Stigma
$571,718Brenda N Major · University Of California Santa Barbara · R01 · FY2014 · HL